[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zhang et al., 2007 - Google Patents

Tissue and BAL based biomarkers in asthma

Zhang et al., 2007

Document ID
4142368396145207227
Author
Zhang J
Wenzel S
Publication year
Publication venue
Immunology and allergy clinics of North America

External Links

Snippet

Asthma is a heterogeneous disease with multiple phenotypes. There are no tissue or bronchoalveolar lavage biomarkers that are “specific” for asthma. Markers associated with eosinophilic, neutrophilic, and paucigranulocytic asthma are discussed here, and those for …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Zhang et al. Tissue and BAL based biomarkers in asthma
Toda et al. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma
Trejo Bittar et al. Pathobiology of severe asthma
Chu et al. Transforming growth factor-β2 induces bronchial epithelial mucin expression in asthma
Reeves et al. Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components
Nouri-Aria et al. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy
Kicic et al. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma
Brightling et al. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis
Tillie‐Leblond et al. Airway remodeling is correlated with obstruction in children with severe asthma
Balzar et al. Increased TGF-β2 in severe asthma with eosinophilia
Nouri-Aria et al. Basophil recruitment and IL-4 production during human allergen-induced late asthma
Kotaru et al. Regional fibroblast heterogeneity in the lung: implications for remodeling
Bergeron et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide
Keatings et al. Late response to allergen is associated with increased concentrations of tumor necrosis factor-α and IL-5 in induced sputum
Joubert et al. CCR3 expression and function in asthmatic airway smooth muscle cells
Rovina et al. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease
Lazaar et al. Is airway remodeling clinically relevant in asthma?
Muro et al. Expression of IL-15 in inflammatory pulmonary diseases
Fang et al. Resistin‐like molecule‐β (RELM‐β) targets airways fibroblasts to effect remodelling in asthma: from mouse to man
Pujols et al. Expression of glucocorticoid receptors α and β in steroid sensitive and steroid insensitive interstitial lung diseases
Koh et al. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans
Karjalainen et al. Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma
Kanemitsu et al. Factors contributing to an accelerated decline in pulmonary function in asthma
Pechkovsky et al. Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II
Reddy et al. Sexual dimorphism in chronic respiratory diseases